Publications by authors named "Tiziano Barbui"

100Publications

Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management.

Am J Hematol 2020 12 23;95(12):1599-1613. Epub 2020 Oct 23.

Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.

View Article and Find Full Text PDF
December 2020

From leeches to interferon: should cytoreduction be prescribed for all patients with polycythemia vera?

Leukemia 2020 11 16;34(11):2837-2839. Epub 2020 Jul 16.

Foundation of Clinical Research-FROM, Ospedale Papa Giovanni XXIII, Bergamo, Italy.

View Article and Find Full Text PDF
November 2020

An agenda for future research projects in polycythemia vera and essential thrombocythemia.

Haematologica 2020 Aug 28;105(8):1999-2003. Epub 2020 May 28.

Department of Oncology and Hematology, University of Milan, Milan and Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.

View Article and Find Full Text PDF
August 2020

The new WHO classification for essential thrombocythemia calls for revision of available evidences.

Blood Cancer J 2020 02 25;10(2):22. Epub 2020 Feb 25.

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

View Article and Find Full Text PDF
February 2020

Leukocytosis and thrombosis in polycythemia vera: can clinical trials settle the debate?

Blood Adv 2019 12;3(23):3951-3952

FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.

View Article and Find Full Text PDF
December 2019

Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin.

Leukemia 2020 04 7;34(4):1208-1209. Epub 2019 Nov 7.

Institute of Hematology, Catholic University, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

View Article and Find Full Text PDF
April 2020

Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in Polycythemia Vera.

Blood Cancer J 2018 11 26;8(12):124. Epub 2018 Nov 26.

Department of Experimental and Clinical Medicine, Center of Research and Innovation of Myeloproliferative neoplasms (CRIMM), AOU Careggi, University of Florence, Florence, Italy.

View Article and Find Full Text PDF
November 2018

Targeting myeloid cells to prevent recurrent stroke in general population: the lesson of hydroxyurea in myeloproliferative neoplasms.

Blood Cancer J 2018 11 7;8(11):103. Epub 2018 Nov 7.

Fondazione Policlinico Universitario A. Gemelli IRCCS, and Istituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy.

View Article and Find Full Text PDF
November 2018

Prefibrotic myelofibrosis: treatment algorithm 2018.

Blood Cancer J 2018 11 7;8(11):104. Epub 2018 Nov 7.

FROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy.

View Article and Find Full Text PDF
November 2018

Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.

Am J Hematol 2019 01 9;94(1):133-143. Epub 2018 Nov 9.

Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.

View Article and Find Full Text PDF
January 2019

Evidence- and consensus-based recommendations for phlebotomy in polycythemia vera.

Leukemia 2018 09 28;32(9):2077-2081. Epub 2018 Jun 28.

Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.

View Article and Find Full Text PDF
September 2018

Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018.

Blood Cancer J 2018 06 26;8(7):64. Epub 2018 Jun 26.

FROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy.

View Article and Find Full Text PDF
June 2018

Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms.

Blood Cancer J 2018 06 26;8(7):65. Epub 2018 Jun 26.

FROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy.

View Article and Find Full Text PDF
June 2018

Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: A systematic review.

Am J Hematol 2018 05 10;93(5):698-703. Epub 2018 Feb 10.

Research Foundation FROM, Papa Giovanni XXIII Hospital, Piazza OMS 1, 24127 Bergamo, Italy.

View Article and Find Full Text PDF
May 2018

Incidence of solid tumors in polycythemia vera treated with phlebotomy with or without hydroxyurea: ECLAP follow-up data.

Blood Cancer J 2018 01 16;8(1). Epub 2018 Jan 16.

FROM Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.

View Article and Find Full Text PDF
January 2018

Polycythemia vera treatment algorithm 2018.

Blood Cancer J 2018 01 10;8(1). Epub 2018 Jan 10.

Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.

View Article and Find Full Text PDF
January 2018

Essential thrombocythemia treatment algorithm 2018.

Blood Cancer J 2018 01 10;8(1). Epub 2018 Jan 10.

Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.

View Article and Find Full Text PDF
January 2018

MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.

J Clin Oncol 2018 02 9;36(4):310-318. Epub 2017 Dec 9.

Paola Guglielmelli, Giada Rotunno, Carmela Mannarelli, Annalisa Pacilli, Francesco Mannelli, and Alessandro M. Vannucchi, University of Florence, Azienda Ospedaliero Universitaria Careggi, Florence; Elisa Rumi, Vittorio Rosti, Giovanni Barosi, and Mario Cazzola, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo; Elisa Rumi and Mario Cazzola, University of Pavia, Pavia; Alessandro Rambaldi, University of Milan, Milan; Alessandro Rambaldi and Tiziano Barbui, Azienda Socio sanitaria Territoriale Papa Giovanni XXIII, Bergamo; Francesco Passamonti, University of Insubria, Varese, Italy; and Terra L. Lasho, Mythri Mudireddy, Maura Nicolosi, Animesh Pardanani, Curtis A. Hanson, Rhett P. Ketterling, Naseema Gangat, and Ayalew Tefferi, Mayo Clinic, Rochester, MN.

View Article and Find Full Text PDF
February 2018

Myeloproliferative Neoplasms.

N Engl J Med 2017 08;377(9):894-5

Mayo Clinic, Rochester, MN

View Article and Find Full Text PDF
August 2017

No correlation of intensity of phlebotomy regimen with risk of thrombosis in polycythemia vera: evidence from European Collaboration on Low-Dose Aspirin in Polycythemia Vera and Cytoreductive Therapy in Polycythemia Vera clinical trials.

Haematologica 2017 06 2;102(6):e219-e221. Epub 2017 Mar 2.

Department of Experimental and Clinical Medicine, CRIMM-Centro Ricerca e Innovazione delle Malattie Mieloproloiferative, Azienda ospedaliera-Universitaria Careggi, University of Florence, Italy.

View Article and Find Full Text PDF
June 2017

ACE inhibitors and cytoreductive therapy in polycythemia vera.

Blood 2017 03 27;129(9):1226-1227. Epub 2016 Dec 27.

FROM Research Foundation, Papa Giovanni XIII Hospital, Bergamo, Italy.

View Article and Find Full Text PDF
March 2017

Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.

Am J Hematol 2017 Jan;92(1):94-108

Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.

View Article and Find Full Text PDF
January 2017

Management of venous thromboembolism in myeloproliferative neoplasms.

Curr Opin Hematol 2017 03;24(2):108-114

aFROM Research Foundation, Ospedale Papa Giovanni XXIII, Bergamo bInstitute of Hematology, Catholic University, Rome, Italy.

View Article and Find Full Text PDF
March 2017

Molecular biomarkers of thrombosis in myeloproliferative neoplasms.

Thromb Res 2016 Apr;140 Suppl 1:S71-5

Division of Immunohematology and Transfusion Medicine, Papa Giovanni XXIII Hospital, Bergamo, Italy.

View Article and Find Full Text PDF
April 2016

Refining prognostication of thrombosis in ET.

Authors:
Tiziano Barbui

Am J Hematol 2016 Jun;91(4):361-3

Foundation for Clinical Research, Hospital Papa Giovanni XXIII, Bergamo, Italy.

View Article and Find Full Text PDF
June 2016

Myeloproliferative neoplasms: Morphology and clinical practice.

Am J Hematol 2016 Jun;91(4):430-3

Hematology division, Mayo Clinic, Rochester, Minnesota.

View Article and Find Full Text PDF
June 2016

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.

J Clin Oncol 2016 Jan 23;34(2):151-9. Epub 2015 Nov 23.

Holly Geyer, Robyn Scherber, Heidi Kosiorek, Amylou C. Dueck, and Ruben A. Mesa, Mayo Clinic, Scottsdale, AZ; Jean-Jacques Kiladjian, Hospital Saint-Louis, Paris; Francoise Boyer, Centre Hospitalier Universitaire, Angers; Gabriel Etienne, Institut Bergonie, Bordeaux; Jean-Christophe Ianotto, Centre Hospitalier Universitaire, Brest; Dana Ranta, Centre Hospitalier Universitaire, Grenoble; Lydia Roy, Centre Hospitalier Universitaire, Poitiers; Jean-Yves Cahn, Centre Hospitalier Universitaire, Grenoble, France; Zhijian Xiao, Zefeng Xu, Yue Zhang, Xiujuan Sun, Junqing Xu, and Peihong Zhang, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China; Stefanie Slot and Sonja Zweegman, VU University Medical Center, Amsterdam; Peter A.W. te Boekhorst, Erasmus Medical Center, Rotterdam; Suzan Commandeur, Leiden University Medical Center, Leiden; Harry Schouten, Maastricht University Medical Center, Maastricht, the Netherlands; Frederico Sackmann, Fundaleu, Buenos Aires, Argentina; Ana Kerguelen Fuentes and Dolores Hernández-Maraver, University Hospital La Paz, Madrid; Carlos Besses, Hospital del Mar; Francisco Cervantes, University of Barcelona, Barcelona, Spain; Konstanze Döhner and Frank Stegelmann, University Hospital of Ulm; Karin Bonatz and Andreas Reiter, Universitätsmedizin Mannheim, Mannheim; Heike L. Pahl, University Hospital Freiburg, Freiburg; Martin Griesshammer, Johannes Wesling Klinikum Minden, Germany; Claire N. Harrison and Deepti Radia, Guy's and St Thomas NHS Foundation Trust; Robert Peter Gale, Imperial College, London, United Kingdom; Pablo Muxi, Hospital Británico, Montevideo, Uruguay; Peter L. Johansson and Bjorn Andreasson, NU Hospital Organization, Uddevalla; Gunnar Birgegard, University Hospital, Uppsala; Jan Samuelsson, Stockholm South Hospital, Stockholm, Sweden; Alessandro Rambaldi, Tiziano Barbui, and Maria L. Ferrari, Ospedali Riuniti di Bergamo, Bergamo; Giovanni Barosi, IRCCS Policlinico S. Matteo Foundation; Franc

View Article and Find Full Text PDF
January 2016

Essential Thrombocythemia and Polycythemia Vera: Focus on Clinical Practice.

Mayo Clin Proc 2015 Sep;90(9):1283-93

Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.

View Article and Find Full Text PDF
September 2015

New and treatment-relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera.

Am J Hematol 2015 Aug;90(8):683-5

Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy.

View Article and Find Full Text PDF
August 2015

Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.

Am J Hematol 2015 Feb;90(2):162-73

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article and Find Full Text PDF
February 2015

Cancer survivorship programs: time for concerted action.

Haematologica 2014 Aug;99(8):1273-6

Haematology, Medical Faculty, University of Basel, Switzerland.

View Article and Find Full Text PDF
August 2014

Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients.

Am J Hematol 2014 Jun 3;89(6):588-90. Epub 2014 Mar 3.

Research Foundation, Papa Giovanni XXIII Hospital, Bergamo, Italy; Division of Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy.

View Article and Find Full Text PDF
June 2014

Are MPNs vascular diseases?

Curr Hematol Malig Rep 2013 Dec;8(4):307-16

Division of Hematology, Ospedale Papa Giovanni XXIII, Piazza OMS, 1, 24127, Bergamo, BG, Italy,

View Article and Find Full Text PDF
December 2013